The National Institute for Health and Care Excellence (NICE) is producing guidance on using biomarker tests (Actim Partus, PartoSure and the Rapid fFN 10Q Cassette Kit) in the NHS in England. The diagnostics advisory committee has considered the evidence base and the views of clinical and patient experts.
The advisory committee is interested in receiving comments on the following:
- Has all of the relevant evidence been taken into account?
- Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
- Are the provisional recommendations sound, and a suitable basis for guidance to the NHS?
The consultation will close on 3rd April. More details available from NICE here